Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease.
J Microbiol Immunol Infect
; 50(4): 541-544, 2017 Aug.
Article
in En
| MEDLINE
| ID: mdl-28720319
ABSTRACT
We retrospectively analyzed data of 38 elderly patients, each with an underlying disease, to evaluate peramivir safety and efficacy. Six patients (15.8%) experienced adverse events, all tolerated. Median time from administration until the return to normal temperatures was 31.5 h (95% CI 22.4-40.6). Results confirm intravenous peramivir's usefulness.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Cyclopentanes
/
Influenza, Human
/
Guanidines
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Year:
2017
Type:
Article